IBSA Pharma recalls TIROSINT levothyroxine oral solution (200 mcg/mL) with subpotent drug risk. Affected units have specific NDC and lot numbers. Contact for remedy details.
Subpotent Drug
IBSA Pharma is recalling TIROSINT levothyroxine oral solution because it may not contain enough active ingredient. This could lead to improper thyroid hormone levels if used without medical supervision.
The product may contain less active levothyroxine than labeled, which could result in inadequate thyroid hormone levels. This might cause symptoms like fatigue, weight gain, or depression if not properly managed by a healthcare provider.
People prescribed TIROSINT levothyroxine by a doctor who received this specific product batch. Those with thyroid conditions are most at risk if the dose is insufficient.
Check for the NDC code 71858-0160-5 on the product label. The lot numbers 220418 (expiring 10/2023) or 220560 (expiring 11/2023) indicate affected batches.
Look for NDC 71858-0160-5 and lot numbers 220418 or 220560 on the TIROSINT oral solution packaging.
The recall states it may have subpotent drug levels, meaning it might not contain enough active ingredient. Consult your doctor before using.
Check for NDC 71858-0160-5 and lot numbers 220418 (expiring 10/2023) or 220560 (expiring 11/2023) on the product label.
The recall does not specify a remedy, so contact your doctor or pharmacy for guidance.
We’ve drafted a message you can send IBSA Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0345-2023 — IBSA Pharma IBSA Pharma Hello, I own a IBSA Pharma that is covered by recall D-0345-2023 from IBSA Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
